Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE

BACKGROUND: Demonstration of clinical benefits on disability progression measures is an important attribute of effective multiple sclerosis (MS) treatments. OBJECTIVE: Examine efficacy of daclizumab beta versus intramuscular (IM) interferon beta-1a on measures of disability progression in patient su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler
Main Authors: Cohan, Stanley, Kappos, Ludwig, Giovannoni, Gavin, Wiendl, Heinz, Selmaj, Krzysztof, Havrdová, Eva Kubala, Rose, John, Greenberg, Steven, Phillips, Glenn, Ma, Wei, Wang, Ping, Lima, Gabriel, Sabatella, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Original Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282160/
https://ncbi.nlm.nih.gov/pubmed/28984179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517735190
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados